1971. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of a Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody (MK-1654) in Healthy Subjects

BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection and hospitalization in infants. Prophylaxis for RSV infection is only recommended for the highest risk infants, leaving the majority of infants unprotected. MK-1654 is a fully human monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Aliprantis, Antonios, Wolford, Dennis, Caro, Luzelena, Maas, Brian, Ma, Hua, Vora, Kalpit, Geng, Dong, Railkar, Radha, Lee, Andrew, Sterling, Laura, Lai, Eseng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254819/
http://dx.doi.org/10.1093/ofid/ofy210.1627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254819/
http://dx.doi.org/10.1093/ofid/ofy210.1627

Ejemplares similares